NO144468C - Fremgangsmaate for fremstilling av et fast stoff som inneholder en meldroeye-alkaloid-komponent - Google Patents

Fremgangsmaate for fremstilling av et fast stoff som inneholder en meldroeye-alkaloid-komponent

Info

Publication number
NO144468C
NO144468C NO763446A NO763446A NO144468C NO 144468 C NO144468 C NO 144468C NO 763446 A NO763446 A NO 763446A NO 763446 A NO763446 A NO 763446A NO 144468 C NO144468 C NO 144468C
Authority
NO
Norway
Prior art keywords
dry
procedure
preparation
solid substance
substance containing
Prior art date
Application number
NO763446A
Other languages
English (en)
Norwegian (no)
Other versions
NO144468B (no
NO763446L (fr
Inventor
Lothar Ehrhardt
Volker Hartmann
Karl-Heinz Otto
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of NO763446L publication Critical patent/NO763446L/no
Publication of NO144468B publication Critical patent/NO144468B/no
Publication of NO144468C publication Critical patent/NO144468C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO763446A 1975-10-17 1976-10-08 Fremgangsmaate for fremstilling av et fast stoff som inneholder en meldroeye-alkaloid-komponent NO144468C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2546577A DE2546577B2 (de) 1975-10-17 1975-10-17 Feste Stoffe aus Polyvinylpyrrolidon und Ergotalkaloiden

Publications (3)

Publication Number Publication Date
NO763446L NO763446L (fr) 1977-04-19
NO144468B NO144468B (no) 1981-06-01
NO144468C true NO144468C (no) 1981-09-09

Family

ID=5959411

Family Applications (1)

Application Number Title Priority Date Filing Date
NO763446A NO144468C (no) 1975-10-17 1976-10-08 Fremgangsmaate for fremstilling av et fast stoff som inneholder en meldroeye-alkaloid-komponent

Country Status (28)

Country Link
JP (1) JPS5854122B2 (fr)
AT (1) AT362510B (fr)
AU (1) AU508628B2 (fr)
BE (1) BE847368A (fr)
CA (1) CA1079641A (fr)
CH (1) CH643737A5 (fr)
CS (1) CS199647B2 (fr)
DE (1) DE2546577B2 (fr)
DK (1) DK146194C (fr)
ES (1) ES452420A1 (fr)
FI (1) FI762875A (fr)
FR (1) FR2327764A1 (fr)
GB (1) GB1560406A (fr)
GR (1) GR61268B (fr)
HK (1) HK3183A (fr)
HU (1) HU172533B (fr)
IE (1) IE43778B1 (fr)
IL (1) IL50686A (fr)
MY (1) MY8400063A (fr)
NL (1) NL184558C (fr)
NO (1) NO144468C (fr)
NZ (1) NZ182341A (fr)
PH (1) PH14513A (fr)
PT (1) PT65719B (fr)
SE (1) SE430379B (fr)
SG (1) SG63082G (fr)
SU (1) SU1165223A3 (fr)
ZA (1) ZA766166B (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1572226A (en) * 1977-11-03 1980-07-30 Hoechst Uk Ltd Pharmaceutical preparations in solid unit dosage form
DK154607C (da) * 1978-12-21 1989-06-05 Sandoz Ag Fremgangsmaade til fremstilling af en laegemiddelform til oral administration af ergotalkaloider
US4411882A (en) 1978-12-21 1983-10-25 Sandoz Ltd. Galenical compositions
FR2454804B1 (fr) * 1979-04-26 1986-11-21 Sanofi Sa Medicament a base de dihydroergotoxine et son procede de preparation
US4366145A (en) * 1981-06-24 1982-12-28 Sandoz, Inc. Soft gelatin capsule with a liquid ergot alkaloid center fill solution and method of preparation
US4898729A (en) * 1983-12-09 1990-02-06 Euroceltique, S.A. Treatment of hypertension, compounds and compositions for antihypertension and diuresis
NL194389C (nl) * 1984-06-14 2002-03-04 Novartis Ag Werkwijze voor het bereiden van een vaste dispersie van een farmaceutisch actief middel dat een lage oplosbaarheid in water heeft, in een vaste matrix van een in water oplosbaar polyalkyleenglycol als drager.
ATE72111T1 (de) * 1987-01-14 1992-02-15 Ciba Geigy Ag Therapeutisches system fuer schwerloesliche wirkstoffe.
FR2610827B1 (fr) * 1987-02-18 1991-09-13 Pf Medicament Comprime de dihydroergotamine (d.h.e.) du type a matrice hydrophile et son procede de fabrication
US5064656A (en) * 1989-11-14 1991-11-12 Dr. Gergely & Co. Uncoated pharmaceutical reaction tablet
DE4401646A1 (de) * 1994-01-21 1995-07-27 Krewel Werke Gmbh Optimal freisetzende Kava-Extrakte
US6524832B1 (en) 1994-02-04 2003-02-25 Arch Development Corporation DNA damaging agents in combination with tyrosine kinase inhibitors
MY126580A (en) * 1997-12-22 2006-10-31 Merck Sharp & Dohme Molecular dispersion composition with enchanced bioavailabity
US6632455B2 (en) 1997-12-22 2003-10-14 Schering Corporation Molecular dispersion composition with enhanced bioavailability
US6316462B1 (en) 1999-04-09 2001-11-13 Schering Corporation Methods of inducing cancer cell death and tumor regression
ES2236017T3 (es) * 1999-12-03 2005-07-16 Polichem S.A. Procedimientos para la prepaaraciones farmaceuticas de liberacion sostenida de alcaloides del ergot que tienen biodfisponibilidad mejorada y composiciones de los mismos.
US7771746B2 (en) 1999-12-03 2010-08-10 Polichem Sa Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof
US7135436B2 (en) 2003-05-05 2006-11-14 J.F. Daley International, Ltd. Solid algicide, preparation and usage in recirculating water
US20060141038A1 (en) * 2003-06-27 2006-06-29 Bioprogress S. P. A. Composite product obtainable by cogrinding of a active principle with a copolymer n-vinyl-2 pyrrolidone/vinyl-acetate

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1175430A (en) * 1966-04-07 1969-12-23 Sandoz Ltd Pharmaceutical Compositions containing Ergot Alkaloids

Also Published As

Publication number Publication date
DE2546577A1 (de) 1977-04-21
AT362510B (de) 1981-05-25
SE7611189L (sv) 1977-04-18
NL184558C (nl) 1989-09-01
FR2327764B1 (fr) 1979-03-02
AU508628B2 (en) 1980-03-27
SG63082G (en) 1983-09-09
ATA767976A (de) 1980-10-15
HK3183A (en) 1983-01-20
PT65719A (fr) 1976-11-01
SE430379B (sv) 1983-11-14
SU1165223A3 (ru) 1985-06-30
AU1875476A (en) 1978-04-20
PT65719B (fr) 1978-06-12
IL50686A (en) 1979-05-31
JPS5854122B2 (ja) 1983-12-02
NZ182341A (en) 1978-09-20
NL7611295A (nl) 1977-04-19
FR2327764A1 (fr) 1977-05-13
GR61268B (en) 1978-10-17
CS199647B2 (en) 1980-07-31
NL184558B (nl) 1989-04-03
CA1079641A (fr) 1980-06-17
PH14513A (en) 1981-08-24
MY8400063A (en) 1984-12-31
HU172533B (hu) 1978-09-28
DK146194B (da) 1983-07-25
ES452420A1 (es) 1978-04-16
NO144468B (no) 1981-06-01
DE2546577B2 (de) 1981-04-02
DK454176A (da) 1977-04-18
IL50686A0 (en) 1976-12-31
CH643737A5 (en) 1984-06-29
GB1560406A (en) 1980-02-06
ZA766166B (en) 1978-05-30
DK146194C (da) 1984-01-02
IE43778B1 (en) 1981-05-20
JPS5251014A (en) 1977-04-23
NO763446L (fr) 1977-04-19
FI762875A (fr) 1977-04-18
BE847368A (fr) 1977-04-15
IE43778L (en) 1977-04-17

Similar Documents

Publication Publication Date Title
SE433208B (sv) Forfarande for framstellning av fenoletrar
DK484876A (da) Fremgangsmade til fremstilling af 2-phenyl-3-aroylbenzothiophener og -thiophen-1-oxider
DK424476A (da) Fremgangsmade til fremstilling af svovlholdige organosiliciumforbindelser
NO144209C (no) Fremgangsmaate for fremstilling av dialkylkarbonater
SE426944B (sv) Forfarande for framstellning av alkylenkarbonater
NO144468C (no) Fremgangsmaate for fremstilling av et fast stoff som inneholder en meldroeye-alkaloid-komponent
SE7605139L (sv) Forfarande for framstellning av vattenupptagande cellulosaetrar
SE430336B (sv) Forbettrat forfarande for framstellning av amoxicillinfrihydrat
SE433610B (sv) Forfarande for framstellning av aromatiska uretaner
DK149194C (da) Fremgangs-maade til fremstilling af (r)-n-phenylalaninderivater
SE433937B (sv) Forfarande for framstellning av penicillinestrar
AR211273A1 (es) Procendimiento de preparacion de nuevas (fenoxi-4-fenil)1-piperazinas
NO139555C (no) Fremgangsmaate for fremstilling av fosgen
NO146058C (no) Analogifremgangsmaate for fremstilling av substituerte benzamider
SE7607786L (sv) Forfarande for framstellning av sulfamylbensylforeningar
SE443142B (sv) Forfarande for framstellning av rifamycinforeningar
SE7606116L (sv) Forfarande for framstellning av 3-fenoxidbensaldehyder
DK143946C (da) Fremgangsmaade til fremstilling af et vaskepulver
SE7604781L (sv) Forfarande for framstellning av diarylhydroxibutylaminer
NO144739C (no) Fremgangsmaate for fremstilling av presset torvsubstrat
SE7600754L (sv) Forfarande for framstellning av svavelinnehallande oktapeptidderivat
SE427841B (sv) Analogiforfarande for framstellning av tienamycinderivat
SE434156B (sv) Forfarande for framstellning av penicilliner
SE404186B (sv) Forfarande for framstellning av cyklopropanolderivat
SE446726B (sv) Forfarande for framstellning av 16-metoxiprostaglandiner